UCLA discovery sheds light on why Alzheimer's meds rarely help

Likely culprit has different molecular structure than current drugs' target

2013-07-01

(Press-News.org) BACKGROUND

The Alzheimer's Association projects that the number of people living with Alzheimer's disease will soar from 5 million to 13.8 million by 2050 unless scientists develop new ways to stop the disease. Current medications do not treat Alzheimer's or stop it from progressing; they only temporarily lessen symptoms, such as memory loss and confusion.

Current Alzheimer's drugs aim to reduce the amyloid plaques—sticky deposits that build up in the brain--that are a visual trademark of the disease. The plaques are made of long fibers of a protein called Amyloid β, or Aβ. Recent studies, however, suggest that the real culprit behind Alzheimer's may be small Aβ clumps called oligomers that appear in the brain years before plaques develop.

FINDINGS

In unraveling oligomers' molecular structure, UCLA scientists discovered that Aβ has a vastly different organization in oligomers than in amyloid plaques. Their finding could shed light on why Alzheimer's drugs designed to seek out amyloid plaques produce zero effect on oligomers.

IMPACT

The UCLA study suggests that recent experimental Alzheimer's drugs failed in clinical trials because they zero in on plaques and do not work on oligomers. Future studies on oligomers will help speed the development of new drugs specifically aiming at Aβ oligomers.

INFORMATION:

AUTHORS

Zhefeng Guo, an assistant professor of neurology at the David Geffen School of Medicine at UCLA and a member of UCLA's Brain Research Institute and Molecular Biology Institute, is available for interviews.

JOURNAL

The study was published as Paper of the Week in the June 28 issue of the peer-reviewed Journal of Biological Chemistry.

GRAPHICS

Images of Aβ oligomers and Aβ fibers are available upon request.

FUNDING

The research was supported by the Alzheimer's Association and American Health Assistance Foundation.

ELSE PRESS RELEASES FROM THIS DATE:

DNA particles in the blood may help speed detection of coronary artery disease

2013-07-01

DALLAS, July 1, 2013 — DNA fragments in your blood may someday help doctors quickly learn if chest pain means you have narrowed heart arteries, according to a new study published in the American Heart Association journal Arteriosclerosis, Thrombosis, and Vascular Biology. The study involved 282 patients, ages 34 to 83, who reported chest pain and were suspected of having coronary artery disease. Researchers used computed tomography imaging to look for hardened, or calcified, buildup in the blood vessels that supply the heart. Blood samples also were tested for bits of ...

New guidelines pave the road for achieving an AIDS-free generation

2013-07-01

KUALA LUMPUR—July 1, 2013—The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) welcomes the World Health Organization (WHO)'s new HIV/AIDS treatment and prevention guidelines. For the first time, the 2013 guidelines combine recommendations across the continuum of HIV care and prevention programs, including expanding treatment eligibility for HIV-positive pregnant women, mothers, and children. These recommendations signify a major step forward in the global effort to achieve an AIDS-free generation, but will require a significant shift in current implementation efforts. ...

Researchers have discovered a new proteasome regulatory mechanism

2013-07-01

Dysfunction of the ubiquitin-proteasome system is related to many severe neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases, and certain types of cancer. Such dysfunction is also believed to be related to some degenerative muscle diseases. The proteasome is a large protein complex that maintains cellular protein balance by degrading and destroying damaged or expired proteins. The ubiquitin is a small protein that labels proteins for destruction for the proteasome. If the system does not work effectively enough, expired and damaged proteins accumulate ...

ACRG and BGI report new evidence for the genetic bases of liver cancer

2013-07-01

July 1, 2013, Shenzhen, China – The Asian Cancer Research Group (ACRG), an independent, not-for-profit company in collaboration with BGI, the world's largest genomics organization, and The University of Hong Kong (HKU), jointly announced the publication of findings from a study of recurrent mutations in hepatocellular carcinoma (HCC), one of the most deadly cancers worldwide, in the international journal Genome Research. The study provides new insights into potential therapeutic intervention strategies for this common form of liver cancer. HCC is a primary malignancy ...

New treatment for schizophrenia discovered in Finland

2013-07-01

A research group led by professor Jesper Ekelund showed that by giving a very large dose of famotidine (200 mg daily), sufficient amounts of the drug are able to penetrate the so-called blood-brain barrier to affect the histamine system in the brain. Famotidine has been used for the treatment of heartburn since the 1980s, but at regular dosing, famotidine almost does not enter the brain at all, since the brain is protected by the blood-brain barrier. By increasing the dosage five-fold the drug is able to enter the brain and affect the histamine system. - Already after ...

Curious mix of precision and brawn in a pouched super-predator

2013-07-01

SYDNEY: A bizarre, pouched super-predator that terrorized South America millions of years ago had huge sabre-like teeth but its bite was weaker than that of a domestic cat, new research shows. Australian and American marsupials are among the closest living relatives of the extinct Thylacosmilus atrox, which had tooth roots extending rearwards almost into its small braincase. "Thylacosmilus looked and behaved like nothing alive today," says University of New South Wales palaeontologist, Dr Stephen Wroe, leader of the research team. "To achieve a kill the animal must have ...

A calculator to estimate the likelihood of antidepressant response

2013-07-01

Philadelphia, PA-- As in any other field of medicine, when a depressed person visits a psychiatrist for treatment of depression, they like to be informed of the odds that they will respond to the medication they are prescribed. Unfortunately, there has been no precise way to predict antidepressant response in individual patients. It would be very nice to have an equation that would enable doctors to predict the likelihood that individual patients would respond to specific treatments. Accurate predictions are likely to be challenging. The ability to accurately predict ...

Teaching a computer to play concentration advances security, understanding of the mind

2013-07-01

Computer science researchers have programmed a computer to play the game Concentration (also known as Memory). The work could help improve computer security – and improve our understanding of how the human mind works. The researchers developed a program to get the software system called ACT-R, a computer simulation that attempts to replicate human thought processes, to play Concentration. In the game, multiple matching pairs of cards are placed face down in a random order, and players are asked to flip over two cards, one at a time, to find the matching pairs. If a player ...

Too much of a good thing? Too many 'healing' cells delays wound healing

2013-07-01

Bethesda, MD -- Like most other things, you can have too much of a good thing when it comes to wound healing, and new research proves it. According to an article published in the July 2013 issue of the Journal of Leukocyte Biology, wound healing can be delayed because the body produces too many mast cells, which normally promote healing. An overabundance of these cells, however, also causes harm by leading to the overproduction of IL-10, which prevents certain white blood cells from reaching the wounded area. The work was conducted in mice with lymphedematous skin, and ...

Social responsibility, the main motivation of minority-language radio journalism

2013-07-01

This news release is available in Spanish. The UPV/EHU researcher Irati Agirreazkuenaga-Onaindia has developed a new methodology for studying the profiles, working habits and perceptions of Basque and Scottish Gaelic-speaking radio journalists. The study confirms that social responsibility is the main motivation for the EITB and BBC journalists. Euskadi Irratia was 30 years old last year, and the study covers what the journalists who work in minority languages are like and how they go about their work. So the UPV/EHU researcher Irati Agirreazkuenaga has compared ...

UCLA discovery sheds light on why Alzheimer's meds rarely help

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: